The mechanism of action of ALKBH4 in gastric cancer involves reducing the level of H3K4me3 modification in the promoter region of GSDME by acting as a demethylase, leading to the inhibition of GSDME transcriptional activation. Here, GSDME is linked to gastric cancer.